Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-15

FDA Approved: INFANTS MOTRIN — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for Infants Motrin (ibuprofen) filed by Kenvue Brands LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infants Motrin (Ibuprofen)

Snippet

SUPPL AP for INFANTS MOTRIN (IBUPROFEN)